TMPO-AS1
gene geneOn this page
Summary
TMPO-AS1 (TMPO antisense RNA 1, HGNC:44158) is a long non-coding RNA gene on chromosome 12q23.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44158 |
| Approved symbol | TMPO-AS1 |
| Name | TMPO antisense RNA 1 |
| Location | 12q23.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000257167 |
| Ensembl biotype | lncRNA |
| Entrez | 100128191 |
| RNAcentral | URS000075B992 — lncRNA, 3161 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000546421, ENST00000548760, ENST00000733960, ENST00000733961, ENST00000733962
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000546421 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002359707 | 98515477 | 98515897 |
| ENSE00002373951 | 98515991 | 98516210 |
| ENSE00002387340 | 98514400 | 98515390 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 80.65.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8794 / max 107.3582, expressed in 1284 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 132831 | 1.7832 | 845 |
| 132829 | 0.7682 | 373 |
| 132832 | 0.7465 | 450 |
| 132827 | 0.7241 | 354 |
| 132828 | 0.6483 | 367 |
| 132830 | 0.2090 | 113 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.65 | silver quality |
| left testis | UBERON:0004533 | 79.74 | gold quality |
| right testis | UBERON:0004534 | 78.91 | gold quality |
| testis | UBERON:0000473 | 78.14 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.95 | gold quality |
| ventricular zone | UBERON:0003053 | 73.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.17 | gold quality |
| bone marrow cell | CL:0002092 | 72.06 | gold quality |
| monocyte | CL:0000576 | 70.25 | gold quality |
| leukocyte | CL:0000738 | 70.13 | gold quality |
| adult organism | UBERON:0007023 | 69.68 | gold quality |
| stromal cell of endometrium | CL:0002255 | 67.65 | gold quality |
| sperm | CL:0000019 | 67.32 | silver quality |
| cortical plate | UBERON:0005343 | 66.69 | gold quality |
| granulocyte | CL:0000094 | 66.38 | gold quality |
| colonic epithelium | UBERON:0000397 | 65.54 | silver quality |
| vermiform appendix | UBERON:0001154 | 63.32 | gold quality |
| right uterine tube | UBERON:0001302 | 62.68 | gold quality |
| left ovary | UBERON:0002119 | 60.44 | gold quality |
| lymph node | UBERON:0000029 | 60.37 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 60.11 | gold quality |
| ovary | UBERON:0000992 | 59.50 | gold quality |
| spleen | UBERON:0002106 | 58.93 | gold quality |
| caecum | UBERON:0001153 | 58.28 | gold quality |
| right ovary | UBERON:0002118 | 58.25 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 58.21 | gold quality |
| rectum | UBERON:0001052 | 57.46 | gold quality |
| ileal mucosa | UBERON:0000331 | 57.27 | silver quality |
| corpus epididymis | UBERON:0004359 | 56.57 | gold quality |
| blood | UBERON:0000178 | 56.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.17 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 18)
- TMPO-AS1 contributes to lung carcinogenesis, which may be partially through upregulation TMPO. (PMID:31230752)
- TMPO-AS1 is closely associated with the estrogen signaling pathway. TMPO-AS1 could positively regulate estrogen receptor 1 (ESR1) mRNA expression by stabilizing ESR1 mRNA through interaction with ESR1 mRNA. (PMID:31501276)
- LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. (PMID:31680323)
- Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients. (PMID:31768869)
- LncRNA TMPO-AS1 up-regulates the expression of HIF-1alpha and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. (PMID:32139259)
- Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells. (PMID:32497621)
- LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer. (PMID:32692467)
- Inhibition of lncRNA TMPOAS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR1433p. (PMID:32945436)
- LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer. (PMID:32964962)
- LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. (PMID:32969763)
- LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1. (PMID:33215415)
- Down-Regulation of TMPO-AS1 Induces Apoptosis in Lung Carcinoma Cells by Regulating miR-143-3p/CDK1 Axis. (PMID:33685293)
- The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. (PMID:34096793)
- LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome. (PMID:34330309)
- lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis. (PMID:35040749)
- LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. (PMID:35760875)
- Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer. (PMID:38383342)
- LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis. (PMID:39205592)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Loeys-Dietz syndrome 2